Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Imran Ajmal"'
Autor:
William G. La Cava, Paul C. Lee, Imran Ajmal, Xiruo Ding, Priyanka Solanki, Jordana B. Cohen, Jason H. Moore, Daniel S. Herman
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-14 (2023)
Abstract Machine learning (ML) models trained for triggering clinical decision support (CDS) are typically either accurate or interpretable but not both. Scaling CDS to the panoply of clinical use cases while mitigating risks to patients will require
Externí odkaz:
https://doaj.org/article/aae04f346cfd45fbaa7d279a18b6938b
Autor:
Daniel S. Herman, Lingjiao Zhang, Xiruo Ding, Imran Ajmal, Jason H. Moore, Yanyuan Ma, Jinbo Chen, Naveen Muthu
Publikováno v:
J Am Med Inform Assoc
ObjectivePhenotyping patients using electronic health record (EHR) data conventionally requires labeled cases and controls. Assigning labels requires manual medical chart review and therefore is labor intensive. For some phenotypes, identifying gold-
Autor:
Lee Pc, Jordana B. Cohen, Cava Wl, Daniel S. Herman, Jason H. Moore, Imran Ajmal, Solanki P, Xiruo Ding
ObjectiveElectronic health records (EHRs) can improve patient care by enabling systematic identification of patients for targeted decision support. But, this requires scalable learning of computable phenotypes. To this end, we developed the feature e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9dbcc27a4ef4383a5c83f9a8697af10
https://doi.org/10.1101/2020.12.12.20248005
https://doi.org/10.1101/2020.12.12.20248005
Autor:
Xiruo Ding, Imran Ajmal, Debbie L. Cohen, Jordana B. Cohen, Priyanka Solanki, Daniel S. Herman
Publikováno v:
Hypertension. 76
Introduction: Apparent treatment resistant hypertension (aTRH) affects 10-20% of hypertensive adults and increases risk of cardiovascular events and mortality. Fewer than half of these patients have true resistant hypertension. The majority experienc
Autor:
Selina M. Luger, Alison W. Loren, Imran Ajmal, James K. Mangan, Noelle V. Frey, Elizabeth O. Hexner, Martin Carroll
Publikováno v:
Blood. 134:5155-5155
Although deferasirox use is established in clinical practice for iron overload, there have been a spate of case reports describing hematologic improvement attributed to use of this agent in myelodysplastic syndrome (MDS) patients (Guariglia et al, Le